Protein kinase inhibitors

Compounds that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed.

Saved in:
Bibliographic Details
Main Authors Ba-Maung, Nwe Y, Bell, Randy L, Clark, Richard F, Erickson, Scott A, Fidanze, Steve D, Hubbard, Robert D, Mantei, Robert A, Sheppard, George S, Sorensen, Bryan K, Wang, Gary T, Wang, Jieyi
Format Patent
LanguageEnglish
Published 29.11.2011
Online AccessGet full text

Cover

Abstract Compounds that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed.
AbstractList Compounds that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed.
Author Fidanze, Steve D
Wang, Gary T
Wang, Jieyi
Erickson, Scott A
Mantei, Robert A
Sheppard, George S
Bell, Randy L
Clark, Richard F
Hubbard, Robert D
Sorensen, Bryan K
Ba-Maung, Nwe Y
Author_xml – sequence: 1
  givenname: Nwe Y
  surname: Ba-Maung
  fullname: Ba-Maung, Nwe Y
– sequence: 2
  givenname: Randy L
  surname: Bell
  fullname: Bell, Randy L
– sequence: 3
  givenname: Richard F
  surname: Clark
  fullname: Clark, Richard F
– sequence: 4
  givenname: Scott A
  surname: Erickson
  fullname: Erickson, Scott A
– sequence: 5
  givenname: Steve D
  surname: Fidanze
  fullname: Fidanze, Steve D
– sequence: 6
  givenname: Robert D
  surname: Hubbard
  fullname: Hubbard, Robert D
– sequence: 7
  givenname: Robert A
  surname: Mantei
  fullname: Mantei, Robert A
– sequence: 8
  givenname: George S
  surname: Sheppard
  fullname: Sheppard, George S
– sequence: 9
  givenname: Bryan K
  surname: Sorensen
  fullname: Sorensen, Bryan K
– sequence: 10
  givenname: Gary T
  surname: Wang
  fullname: Wang, Gary T
– sequence: 11
  givenname: Jieyi
  surname: Wang
  fullname: Wang, Jieyi
BookMark eNrjYmDJy89L5WSQDCjKL0nNzFPIzsxLLE5VyMzLyEzKLMkvKuZhYE1LzClO5YXS3AwKbq4hzh66pcUFiSWpeSXF8elFiSDKwMLAzNzEwNKYCCUA5qolhw
ContentType Patent
CorporateAuthor Abbott Laboratories
CorporateAuthor_xml – name: Abbott Laboratories
DBID EFH
DatabaseName USPTO Issued Patents
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EFH
  name: USPTO Issued Patents
  url: http://www.uspto.gov/patft/index.html
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
ExternalDocumentID 08067409
GroupedDBID EFH
ID FETCH-uspatents_grants_080674093
IEDL.DBID EFH
IngestDate Mon Mar 06 19:17:52 EST 2023
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-uspatents_grants_080674093
OpenAccessLink https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8067409
ParticipantIDs uspatents_grants_08067409
PatentNumber 8067409
PublicationCentury 2000
PublicationDate 20111129
PublicationDateYYYYMMDD 2011-11-29
PublicationDate_xml – month: 11
  year: 2011
  text: 20111129
  day: 29
PublicationDecade 2010
PublicationYear 2011
References Slamon, D., "Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer that Overexpresses HER2", New England J. Med. vol. 344(11), pp. 783-792, 2001.
Druker, B., "Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome", New England J of Medicine, vol. 344, p. 1038, 2001.
Mathis, G., "HTRF(R) Technology", J. Biomol. Screen, vol. 4(6), pp. 309-314, 1999.
(02066481) 20020800
Khandwala, H., "The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic Growth", Endocrine Reviews, vol. 21, (3), pp. 215-244, 2000.
Pure Appl. Chem, "Rules for the Nomenclature of Organic Chemistry, Section E: Stereochemistry", IUPAC Commission on Nomenclature of Organic Chemistry, Pergamon Press,vol. 45, pp. 13-20, 1976.
(WO2005068452) 20050700
(03000682) 20030100
(2008029152) 20080300
PCT Search Report for PCT/US2008/084469 mailed on Mar. 18, 2009.
(2004110990) 20041200
Rusch, V., "The Epidermal Growth Factor Receptor and Its Ligands as Therapeutic Targets in Human Tumors", Cytokine & Growth Factor Rev. vol. 7, pp. 133-141, 1996.
Loewe, et al., "Ein nener Typ der 4-Amino-chinolin-Reihe", Zrzeneim. Forsch, vol. 16,p. 1306-1310, 1966.
Davies, D., "Targeting the Epidermal Growth Factor Receptor for Therapy of Carcinomas", Biochem. Pharm. vol. 51 (9), pp. 1101-1110, 1996.
Hynes, N., "The biology of erbB-2/neu/HER-2 and its role in cancer", Biochem. Biophys. Acta. vol. 1198, pp. 165-184, 1994.
(02066480) 20020800
Catrina S-B et al., "Insulin-like growth factor-I receptor activity is essential for Kaposi's sarcoma growth and survival", Br. J. Cancer, vol. 92, pp. 1467-147, 2005.
(2007123892) 20071100
Simone, Oncology: Introduction, Cecil Textbook of Medicine, 20th Edition, vol. 1, pp. 1004-1010, 1996.
Lutz, M.P., "Overexpression and Activation of the Tyrosine Kinase Src in Human Pancreatic Carcinoma", Biochemical & Biophysical Research Commun., vol. 243, pp. 503-508, 1998.
Talamonti, M., "Increase in Activity and Level of pp60 c-src in Progressive Stages of Human Colorectal Cancer", J. Clin. Invest. vol. 91, pp. 53-60, 1993.
(WO2006044869) 20060400
(2006094236) 20060900
(0114375) 20010300
(WO2006068826) 20060600
Hirota, S., "Gain of function Mutations of C-kit in Human Gastrointestinal Stromal Tumors", Science, vol. 279, p. 577-580, 1998.
Summy, J., "Src family kinases in tumor progression and metastasis", Cancer & Metastasis Rev. vol. 22, p. 337-358, 2003.
References_xml – year: 20080300
  ident: 2008029152
– year: 20041200
  ident: 2004110990
– year: 20020800
  ident: 02066480
– year: 20020800
  ident: 02066481
– year: 20010300
  ident: 0114375
– year: 20060900
  ident: 2006094236
– year: 20030100
  ident: 03000682
– year: 20060600
  ident: WO2006068826
– year: 20050700
  ident: WO2005068452
– year: 20060400
  ident: WO2006044869
– year: 20071100
  ident: 2007123892
Score 2.8342617
Snippet Compounds that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed.
SourceID uspatents
SourceType Open Access Repository
Title Protein kinase inhibitors
URI https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8067409
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3PS8MwFH7MMVBPypR1_qAHr9myNm2Ts6wUQelBYbeRpKkGXTbWjv37vnQyvCjklMCXhEfelx_vfQF4mIlE1amoSMy0JMjHNRGZ1ISmkUp5wmqt_Ivu80tavLGnRbLoQXHMhVnhMiIbHEsz2TWbdt0FV6J7PxieHMSfvUag8-oDe_e1llVZ1VOObpf5TL4TTn1o1zwvzuEUIXDL5trmF2nkFzAou9pL6Bk3hKD0kgjWhZ_WIXWE1n1YZf1nN1cQ5vPXx4IccZbvWx-fsqQ__cXX0MdzuhlBSCVjVGdxVknKDOdCRYyrWBidIE3OdADBnzDjf9pu4Ky7yMQSiVvot9uduUMmbNV9N81vbmVoUQ
link.rule.ids 230,309,786,808,891,64394
linkProvider USPTO
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3JTsMwEB1VBbGcQIAIZcmBq8FNnMQ-Q6OwVTmA1FsUOw5YFLdqUvH7Haeo4gKST7b0bGvkeV5mngGuhyKSdSwqEjJVEuTjmoikVITGgYx5xGol3YvuyzjO3tjjJJr0INvkwnzhMiJzHEtzs2zm7awLrkT3vjY8WYs_O41A69QHvu10VlZ5Vd9ydLvMZfJtOY51KvqjNNuHXQTBTZttm1-0kR7Adt7VHkJP2yPwcieKYKz_aSySh2_sh5HGfXdzDH46er3LyAaneF-4CJWC_vQYnkAfT-r6FHxaMkZVEiZVSZnmXMiAcRkKrSIkyqHywPsT5uyftivYye_T4vlh_DSAve5WE0sgzqHfLpb6AmmxlZfdjFe7jWtL
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Protein+kinase+inhibitors&rft.inventor=Ba-Maung%2C+Nwe+Y&rft.inventor=Bell%2C+Randy+L&rft.inventor=Clark%2C+Richard+F&rft.inventor=Erickson%2C+Scott+A&rft.inventor=Fidanze%2C+Steve+D&rft.inventor=Hubbard%2C+Robert+D&rft.inventor=Mantei%2C+Robert+A&rft.inventor=Sheppard%2C+George+S&rft.inventor=Sorensen%2C+Bryan+K&rft.inventor=Wang%2C+Gary+T&rft.inventor=Wang%2C+Jieyi&rft.number=8067409&rft.date=2011-11-29&rft.externalDBID=n%2Fa&rft.externalDocID=08067409